-
MANUFACTURERS RAMP UP PURCHASING IN SEPTEMBER AS GLOBAL DEMAND STRENGTHENS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
-
HR Path accelerates its Artificial Intelligence strategy with the acquisition of SnapAI
-
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
-
IT'S BACK. THAT'S BIG. The All-Electric smart #2 Makes Its World Premiere at the Paris Motor Show
-
Anime "Kagurabachi" Unveils Details for Its World Tour Part 3 & Finale!
-
T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer
-
LinkAxia Networks to Deliver Zscaler Zero Trust Security Solutions for Malaysia's Public Sector and GLCs
-
CLASSYS Appoints Former Bain & Company Partner Jung-hee Bae as Chief Commercial Officer to Accelerate Global Expansion
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)
SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and…